# ImmunoVia (Echinacea purpurea extract)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/immunovia
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Echinacea purpurea extract, Purple coneflower extract, Eastern purple coneflower, Hedgehog coneflower, Echinacea angustifolia, American coneflower, Black sampson, Purple echinacea, Rudbeckia purpurea, Brauneria purpurea

## Overview

ImmunoVia is a standardized Echinacea purpurea extract containing active compounds like cichoric acid and alkamides that may enhance [immune function](/ingredients/condition/immune-support). The extract works by stimulating macrophage activity and promoting [cytokine](/ingredients/condition/inflammation) production in immune system pathways.

## Health Benefits

• May support [immune function](/ingredients/condition/immune-support) through stimulation of macrophage activity and cytokine production (preliminary evidence from in vitro/animal studies)
• Traditional use for respiratory tract infections, though specific ImmunoVia clinical trials are not documented
• Potential [anti-inflammatory](/ingredients/condition/inflammation) effects via inhibition of cyclooxygenase and 5-lipoxygenase pathways (based on extract studies)
• May enhance phagocytosis and microbicidal activity in immune cells (preliminary evidence)
• Traditional application for wound healing and chronic pelvic infections (historical use only)

## Mechanism of Action

ImmunoVia works through bioactive compounds including cichoric acid, alkamides, and polysaccharides that interact with immune cells. The extract stimulates macrophage phagocytic activity and enhances production of [pro-inflammatory cytokine](/ingredients/condition/inflammation)s like TNF-α and interleukin-1β. These compounds may also modulate [T-cell](/ingredients/condition/immune-support) responses and complement system activation through toll-like receptor pathways.

## Clinical Summary

Current evidence for ImmunoVia comes primarily from in vitro and animal studies demonstrating immune-stimulating effects. No specific clinical trials on the ImmunoVia branded extract have been published in peer-reviewed journals. General echinacea research shows mixed results, with some studies of 100-400mg daily doses showing modest reductions in cold duration. The evidence quality remains limited due to variability in extract standardization and study methodologies.

## Nutritional Profile

{"macronutrients": {"protein": "Not a significant source", "fiber": "Not a significant source"}, "micronutrients": {"vitamin_C": "Trace amounts, not a significant source", "vitamin_E": "Trace amounts, not a significant source"}, "bioactive_compounds": {"chicoric_acid": "Approximately 0.1-0.2% of extract", "echinacoside": "Approximately 0.1-0.5% of extract", "alkamides": "Approximately 0.01-0.1% of extract", "polysaccharides": "Concentration varies, typically 5-10% of extract"}, "bioavailability_notes": "Bioactive compounds such as alkamides and chicoric acid are considered to have moderate bioavailability, potentially enhanced when taken with food."}

## Dosage & Preparation

No clinically studied dosage ranges are specified for ImmunoVia. General E. purpurea products include capsules standardized at 50:1 ratio or juice standardized to 2.4% β-1,2-D-fructofuranosides, with high-quality extracts containing >6 mg/g alkamides and >15 mg/g cichoric acid. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Echinacea extracts like ImmunoVia are generally well-tolerated, with mild gastrointestinal upset being the most common side effect. Allergic reactions may occur in individuals sensitive to plants in the Asteraceae family, including ragweed and daisies. The extract may theoretically interact with immunosuppressive medications due to its immune-stimulating properties. Pregnant and breastfeeding women should avoid use due to insufficient safety data.

## Scientific Research

No specific human RCTs, meta-analyses, or clinical trials for the branded ImmunoVia extract are documented in the research dossier. General Echinacea purpurea evidence references pharmacological studies for respiratory and wound infections, but without trial specifics, sample sizes, or PubMed PMIDs provided.

## Historical & Cultural Context

Echinacea purpurea has been used in traditional Native American medicine for centuries to treat infections of the upper and lower respiratory tract, wounds, and chronic pelvic infections. The research does not specify historical duration or other traditional medical systems beyond this context.

## Synergistic Combinations

Vitamin C, Zinc, Elderberry, Vitamin D3, Astragalus

## Frequently Asked Questions

### What is the recommended dosage for ImmunoVia echinacea extract?

Specific dosage recommendations for ImmunoVia are not established through clinical trials. General echinacea extract research suggests 300-400mg daily, though optimal dosing for this particular standardized extract requires further study.

### How long does ImmunoVia take to work for immune support?

Based on general echinacea research, potential immune effects may begin within 1-2 weeks of consistent use. However, specific timing data for ImmunoVia extract is not available from dedicated clinical studies.

### Can ImmunoVia be taken with other immune supplements?

No specific interaction studies exist for ImmunoVia with other immune supplements. Combining multiple immune-stimulating compounds may theoretically increase effects, but should be done under healthcare provider guidance to avoid overstimulation.

### Is ImmunoVia better than regular echinacea supplements?

ImmunoVia is a standardized extract, which may provide more consistent bioactive compound levels compared to non-standardized products. However, direct comparative studies between ImmunoVia and other echinacea preparations are not available.

### What are the active compounds in ImmunoVia echinacea extract?

ImmunoVia contains key echinacea bioactives including cichoric acid, alkamides, and polysaccharides. These compounds are responsible for the extract's potential immune-modulating effects through macrophage activation and cytokine production pathways.

### Are there any known side effects or adverse reactions to ImmunoVia echinacea extract?

ImmunoVia echinacea extract is generally well-tolerated, though some users may experience mild gastrointestinal upset, dizziness, or allergic reactions, particularly in individuals with ragweed sensitivity. Long-term safety data specific to the ImmunoVia branded extract is limited, and discontinuation is sometimes recommended after 8–10 weeks of continuous use based on traditional echinacea usage patterns. Anyone with autoimmune conditions should consult a healthcare provider before use, as echinacea may theoretically stimulate immune activity.

### Does ImmunoVia echinacea extract interact with blood thinners or anticoagulant medications?

While direct drug interactions between echinacea and common anticoagulants like warfarin are not well-documented, echinacea may have mild antiplatelet properties based on preliminary research. Individuals taking prescription blood thinners should inform their healthcare provider before supplementing with ImmunoVia to ensure safe concurrent use. Your doctor can assess individual risk factors and monitor blood clotting parameters if needed.

### What does the current research evidence show about ImmunoVia's effectiveness for preventing colds or respiratory infections?

Most clinical evidence for echinacea purpurea relates to general echinacea extracts rather than the ImmunoVia branded product specifically, with mixed results showing modest benefits for cold duration rather than prevention in some studies. ImmunoVia's mechanism—stimulation of macrophage activity and cytokine production—is supported primarily by in vitro and animal studies, not large-scale human trials. While traditional use supports its role in respiratory health, consumers should recognize that ImmunoVia lacks the robust clinical trial data typical of pharmaceuticals.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*